Anna Paini Selected Research

Ezetimibe (Zetia)

3/2022

Reduction of High Cholesterol Levels by a Preferably Fixed-Combination Strategy as the First Step in the Treatment of Hypertensive Patients with Hypercholesterolemia and High/Very High Cardiovascular Risk: A Consensus Document by the Italian Society of Hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Paini Research Topics

Disease

9	Hypertension (High Blood Pressure) 03/2022 - 04/2011
7	Essential Hypertension 01/2023 - 06/2007
3	Neoplasms (Cancer) 01/2021 - 01/2018
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 08/2013
2	Heart Failure 01/2023 - 06/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 08/2016
2	Hypertensive Crisis 01/2019 - 01/2018
1	Type IV Ehlers-Danlos Syndrome 12/2023
1	Stroke (Strokes) 01/2023
1	Hypercholesterolemia 03/2022
1	Diabetes Mellitus 01/2022
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2020
1	Hypertrophy 09/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Cardiomegaly (Heart Hypertrophy) 01/2018
1	Heart Rupture 01/2018
1	Familial Amyloidosis (Hereditary Amyloidosis) 01/2015
1	Amyloidosis 01/2015
1	Infarction (Infarctions) 08/2013
1	Myocardial Infarction 08/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2012
1	Hyperaldosteronism (Conn Syndrome) 09/2008
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2007
1	Chronic Renal Insufficiency 06/2007
1	Migraine Disorders (Migraine) 01/2006
1	Headache (Headaches) 01/2006

Drug/Important Bio-Agent (IBA)

9	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 04/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2018
3	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 10/2017 - 04/2011
2	CalciumIBA 01/2019 - 12/2014
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018 - 08/2013
2	lercanidipineIBA 10/2017 - 03/2014
2	Enalapril FDA LinkGeneric 10/2017 - 03/2014
2	mepirodipine (barnidipine)IBA 08/2011 - 04/2011
1	Celiprolol (ST1396)IBA 12/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	LDL CholesterolIBA 03/2022
1	Bile Acids and Salts (Bile Acids)IBA 03/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022
1	Ezetimibe (Zetia)FDA Link 03/2022
1	HDL CholesterolIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Angiotensin Receptor AntagonistsIBA 01/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018
1	Cocaine (Cocaine HCl)IBA 01/2018
1	DiureticsIBA 01/2018
1	Fibronectins (Fibronectin)IBA 01/2018
1	Laminin (Merosin)IBA 01/2018
1	Retinaldehyde (Retinal)IBA 01/2018
1	elastin microfibril interface located protein (emilin)IBA 01/2018
1	Uric Acid (Urate)IBA 08/2016
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2015
1	Amlodipine (Norvasc)FDA LinkGeneric 08/2013
1	AldosteroneIBA 09/2008
1	CollagenIBA 06/2007
1	Analgesics (Analgesic Drugs)IBA 01/2006

Therapy/Procedure

4	Therapeutics 12/2023 - 06/2017
1	Myocardial Revascularization 01/2023
1	Secondary Prevention 03/2022
1	Biological Therapy 01/2019
1	Renal Dialysis (Hemodialysis) 06/2007